![](/img/cover-not-exists.png)
CIP2A is a target of bortezomib in human triple negative breast cancer cells
Ling-Ming Tseng, Chun-Yu Liu, Kung-Chi Chang, Pei-Yi Chu, Chung-Wai Shiau, Kuen-Feng ChenVolume:
14
Language:
english
DOI:
10.1186/bcr3175
Date:
April, 2012
File:
PDF, 1.13 MB
english, 2012